South and Central America Antacids Market Segments and Growth by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

South and Central America Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

  • Report Code : TIPRE00021093
  • Category : Life Sciences
  • No. of Pages : 133
Buy Now

The South and Central America antacids market is expected to reach US$ 792.18 million in 2027 from US$ 615.58 million in 2019. The market is estimated to grow with a CAGR of 3.3% from 2020-2027.

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate. The scope of the antacids market includes dosage form, drug class, distribution channel, and region.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

SOUTH AND CENTRAL AMERICA ANTACIDS MARKET SEGMENTATION

By Dosage Form

  • Tablet
  • Liquid
  • Others

By Drug Class

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
    • Magaldrate
    • Sucralfate
    • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Country

  • South and Central America

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Procter & Gamble

South and Central America Antacids Report Scope

Report Attribute Details
Market size in 2019 US$ 615.58 Million
Market Size by 2027 US$ 792.18 Million
Global CAGR (2020 - 2027) 3.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Dosage Form
  • Tablet
  • Liquid
By Drug Class
  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    south-and-central-america-antacids-market-report-deliverables-img1
    south-and-central-america-antacids-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Dosage Form, Drug Class, Distribution Channel

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Brazil, Argentina

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    South and Central America Antacids Market
    Connect With Expert
    1. Bayer AG
    2. GlaxoSmithKline plc
    3. Takeda Pharmaceutical Company Limited
    4. Sun Pharmaceutical Industries Ltd
    5. Sanofi
    6. Boehringer Ingelheim International GmbH
    7. Dr. Reddy's Laboratories
    8. Pfizer Inc
    9. Reckitt Benckiser Group Plc
    10. Procter & Gamble
    south-and-central-america-antacids-market-cagr